Aditxt (ADTX) Interest Expenses (2022 - 2026)
Aditxt (ADTX) recorded quarterly Interest Expenses of $27136.0 in Q1 2026, down 90.95% quarter-over-quarter from $299778.0 in Q4 2025, and down 82.77% on a YoY basis from $157499.0 in Q1 2025.
Aditxt (ADTX) Interest Expenses (2022 - 2026) Analysis & Trends
Aditxt's Interest Expenses history runs 5 years deep, the most recent figure standing at $27136.0 for Q1 2026.
- In Q1 2026, Interest Expenses fell 82.77% year-over-year to $27136.0; the TTM figure through Mar 2026 stood at $550793.0 (down 70.34% YoY), while the FY2025 annual figure was $681156.0, down 83.74% from the prior year.
- Interest Expenses was $27136.0 for Q1 2026 at Aditxt, down from $299778.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $2.5 million in Q1 2024 to a low of $12737.0 in Q4 2022.
- Historically, Interest Expenses has averaged $651623.4 across 5 years, with a median of $299778.0 in 2025.
- The sharpest annual moves came in 2023 and 2024: Interest Expenses jumped 14075.24% in 2023, then tumbled 97.9% in 2024.
- A 5-year view of Interest Expenses shows it stood at $12737.0 in 2022, then surged by 14075.24% to $1.8 million in 2023, then sank by 97.9% to $37998.0 in 2024, then jumped by 688.93% to $299778.0 in 2025, then slumped by 90.95% to $27136.0 in 2026.
- The last three Interest Expenses figures came in at $27136.0 (Q1 2026), $299778.0 (Q4 2025), and $176527.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 | 27,136.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27,136.00 |
| Mar 31, 2026 | 27,136.00 |
| Dec 31, 2025 | 299,778.00 |
| Dec 31, 2025 | 299,778.00 |
| Sep 30, 2025 | 176,527.00 |
| Sep 30, 2025 | 176,527.00 |
| Jun 30, 2025 | 47,352.00 |
| Jun 30, 2025 | 47,352.00 |
| Mar 31, 2025 | 157,499.00 |
| Mar 31, 2025 | 157,499.00 |
| Dec 31, 2024 | 37,998.00 |
| Dec 31, 2024 | 37,998.00 |
| Sep 30, 2024 | 570,114.00 |
| Sep 30, 2024 | 570,114.00 |
| Jun 30, 2024 | 1.09 Mn |
| Jun 30, 2024 | 1.09 Mn |
| Mar 31, 2024 | 2.49 Mn |
| Mar 31, 2024 | 2.49 Mn |
| Dec 31, 2023 | 1.81 Mn |
| Dec 31, 2023 | 1.81 Mn |